Skip to main content

Table 1 Reported cases of pure secretory carcinoma in situ

From: Pure secretory carcinoma in situ: a case report and literature review

Author Sex Age (yo) Symptoms/ Duration (month) Site/Location Histological growth pattern Treatment HR HER2 ETV6-NTRK3 Axillary status Follow-up(m)
Kameyama et al [9] M 51 Lump/ND L/Subareolar Papillary, cribriform RM ER+ ND ND -(0/?) NED
Sato et al [10] F 30 Lump/6 L/Lower inner Papillary, cribriform SM + SLNB ER+,PR- NE -(0/2)(SLNB) NED 60
Strauss et al [11] F 73 ND ND ND ND ND ND ND ND ND
F 51 ND ND ND ND ND ND ND ND ND
F 46 ND ND ND ND ND ND ND ND ND
Our case F 38 Bloody nipple discharge/1 L Microcystic, solid,papillary RM + SLNB ER-,PR- + -(0/5)(SLNB) NED 13
  1. Abbreviations: ER, estrogen receptor; F, female; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; L, left breast; M, male; ND, not defined; NE, not examined; NED, not evidence of disease; PR, progesterone receptor; RM, radical mastectomy; SLNB, sentinel lymph node biopsy; SM, simple mastectomy;